Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma

Victor I J Strijbis1,2, Christiaan M de Bloeme3, Robin W Jansen3

  • 1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. v.strijbis@amsterdamumc.nl.

Scientific Reports
|July 17, 2021
PubMed

Insights

Multi-view convolutional neural networks (MV-CNNs) accurately segment ocular structures and tumors in retinoblastoma patients using MRI. This automated approach aids personalized treatment by providing precise eye and tumor segmentation.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Accurate segmentation of ocular structures and tumor tissue is crucial for personalized treatment in retinoblastoma.
  • Current segmentation methods may lack the precision required for complex ocular anatomy and tumor delineation.

Purpose of the Study:

  • To evaluate the performance of multi-view convolutional neural networks (MV-CNNs) for automated segmentation of ocular structures and tumors in retinoblastoma patients using MRI.
  • To assess the impact of different imaging sequences and data augmentation techniques on segmentation accuracy.

Main Methods:

  • A retrospective study utilizing MRI data from 40 retinoblastoma and 20 healthy eyes.
  • Manual delineation of ocular structures and tumors on Fast Imaging Employing Steady-state Acquisition (FIESTA) images served as the reference standard.
  • Multi-view convolutional neural networks (MV-CNNs) were trained and validated, with performance assessed using intra-class correlation (ICC) and dice similarity coefficient (DSC).

Main Results:

  • Optimal MV-CNN performance was achieved using FIESTA, T2, and T1c sequences with data augmentation.
  • High volumetric intra-class correlation coefficients (ICCs) were obtained for eyes (0.997) and tumors (0.996).
  • Median dice similarity coefficients (DSCs) for ocular structures ranged from 0.828 (retinal detachment) to 0.975 (vitreous humour), with tumors achieving a median DSC of 0.914.

Conclusions:

  • Multi-view convolutional neural networks (MV-CNNs) demonstrate high accuracy in segmenting ocular structures and tumors in retinoblastoma patients.
  • This automated segmentation approach shows significant potential for improving personalized treatment strategies in retinoblastoma care.
  • The study highlights the effectiveness of combining multiple MRI sequences and data augmentation for robust segmentation performance.

Related Concept Videos